[Molecular target therapy for malignant lymphoma].
Suzuki
Ritsuro
R
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000627:therapeutic use; D015195:Drug Design; D018390:Gene Targeting; D006801:Humans; D008223:Lymphoma / Q000628:therapy*; D009841:Oligonucleotides / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D016207:Cytokines; D009841:Oligonucleotides; D047428:Protein Kinase Inhibitors